MedPath

HYPAQUE ORAL POWDER 0.9974G/G

HYPAQUE ORAL POWDER 0.9974G/G

Discontinued
DIN Number

02026988

Drug Class

Human

Market Date

Dec 31, 1960

Company
HC

sanofi canada, inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02026988
AIG Number0101806002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AA01 DIATRIZOIC ACID
Product Specifications
Dosage FormPowder
Route of AdministrationOral ,  Rectal
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIATRIZOATE SODIUMActive
Strength: 997.4 MG / G
Monograph: DIATRIZOATE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.